Fennec Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FENC and other ETFs, options, and stocks.

About FENC

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients.

CEO

Jeffrey S Hackman

CEOJeffrey S Hackman

Employees

Employees32

Headquarters

Durham, North Carolina

HeadquartersDurham, North Carolina

Founded

1996

Founded1996

Employees

Employees32

FENC Key Statistics

Market cap

244.09M

Market cap244.09M

Price-Earnings ratio

-20.41

Price-Earnings ratio-20.41

Dividend yield

—

Dividend yield—

Average volume

46.94K

Average volume46.94K

High today

$9.09

High today$9.09

Low today

$8.63

Low today$8.63

Open price

$8.87

Open price$8.87

Volume

58.56K

Volume58.56K

52 Week high

$9.42

52 Week high$9.42

52 Week low

$3.96

52 Week low$3.96

People also own

Based on the portfolios of people who own FENC. This list is generated using Robinhood data, and it’s not a recommendation.